Supply Chain to Patient

BioPhorum members recognize the need to transform the performance of the global supply chain for biologics, and so a team of subject matter experts from across multiple companies is shaping a program of cross-industry collaboration to address topics ranging from capacity constraints, increased costs, and alignment on quality expectations of the outbound supply chain.Lesley Holt, BioPhorum Supply Chain to Patient Director, talks about the complexity of the global supply chain for biologics, the trends she sees emerging, and how this differs from what we see in the news about how the supply chain impacts everyday items. How can your company benefit from collaboration with BioPhorum?

There are no comments yet.

Please log in to write the first comment.